MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease

    A. Gonçalves, A. Mendes, N. Vila-Chã, I. Moreira, S. Cavaco (Porto, Portugal)

    Objective: To explore the predictive value of non-motor symptoms on the cognitive decline of patients with Parkinson’s disease (PD) in a three-year follow up. Background:…
  • 2019 International Congress

    Comparison of autonomic symptoms on Parkinson’s disease and essential tremor with SCOPA-AUT

    J. Gonzalez (Lima, Peru)

    Objective: To compare the presence of autonomic symptoms on Parkinson's disease (PD) and essential tremor (ET) applying the Scale for Outcomes in Parkinson’s disease for…
  • 2019 International Congress

    The frequency of lower urinary tract symptoms in patients with Parkinson’s disease and Clinical efficacy of istradefylline

    Y. Higashi, M. Tabata, T. Tabuchi (Himeji, Japan)

    Objective: We evaluated using the questionnaire to investigate the frequency of lower urinary tract symptoms (LUTSs) in Parkinson's disease at our clinic. For patients with…
  • 2019 International Congress

    Non-Motor Symptoms in Patients with Parkinson’s Disease: Effect of Gender, Disease Severity, and Disease Phenotype

    V. Holla, A. Lenka, S. Chaithra, A. Stezin, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: This study assessed the frequency of NMS in PD and their relationship with gender, severity and PD motor phenotypes. Background: Non-motor symptoms (NMS) is…
  • 2019 International Congress

    Frailty status predicts falls in early Parkinson’s disease

    S. Holland, R. Morris, B. Galna, L. Rochester, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To establish whether there is an association between frailty and falls in early Parkinson’s (PD). Background: PD is a syndrome in which postural control,…
  • 2019 International Congress

    Relationship between RBD and olfactory disorder, clinical symptoms in Parkinson’s disease

    M. Iijima, F. Yoshi, K. Suzuki, S. Nogawa, T. Osada, H. Hirata, K. Kitagawa, N. Hattori, Y. Okuma (Tokyo, Japan)

    Objective: We aimed to assess the association among RBD, olfactory function and clinical symptoms in patients with Parkinson's disease (PD). Background: Rapid eye movement sleep…
  • 2019 International Congress

    Relationship between pain and autonomic symptoms in Parkinson’s Disease: a double-center, cross-sectional, observational study.

    P. Imbriani, P. Ghosh, T. Schirinzi, N. Caputi, L. Covington, A. Sparks, Y. Salnikova, S. Natoli, A. Pisani (Rome, Italy)

    Objective: To investigate the relationship between pain and autonomic symptoms in Parkinson’s disease. Background: Pain is a relevant non-motor symptom (NMS) affecting the quality of…
  • 2019 International Congress

    Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms

    H. Iwaki, M. Tagawa, K. Iwasaki, K. Kawakami, M. Nomoto (Toon, Japan)

    Objective: This study was to compare zonisamide and other anti-PD drugs by analyzing their associations with the incidence of PD-relevant symptoms. Background: Patients with Parkinson’s…
  • 2019 International Congress

    Olfactory dysfunction in Parkinson’s disease

    N. Jalami, H. Bentahar, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: It is to propose a psychophysical test of the olfactory function. Its originality is to use Moroccan odorous products belonging to our culture to…
  • 2019 International Congress

    Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication

    S. Jost, A. Sauerbier, K. Ray-Chaudhuri, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, A. Rizos, A. Schnitzler, P. Löhrer, JN. Petry-Schmelzer, M. Barbe, A. Antonini, P. Martinez-Martin, G. Fink, L. Timmermann, H. Dafsari (Cologne, Germany)

    Objective: To examine 36-month effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms (NMS) and self-reported quality of life compared to…
  • « Previous Page
  • 1
  • …
  • 1178
  • 1179
  • 1180
  • 1181
  • 1182
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley